"Director, I heard that you have suffered from liver cancer for 16 years. In the process of fighting liver cancer, you have a lot of experiences . Are you willing to share with you today?"
"Yes, today I will share with you what I have learned during the process of anti-liver cancer. When you mention liver cancer, bad thoughts will arise. This is human nature, because in everyone's concept, liver cancer is an incurable . In addition, these people have a disgust and disgusted attitude towards liver cancer, which makes them unwilling to understand liver cancer in depth. In fact, liver cancer is not an incurable disease . "
" Dean, why is liver cancer not an incurable disease ? "
" During my 16 years of fighting liver cancer, after thinking about it, I summarized 4 insights . As long as I do these points, liver cancer is not an incurable disease . First: Pay attention to the prevention of liver cancer; second: Early diagnosis and early detection of liver cancer, which wins the opportunity to treat liver cancer; third: Correct understanding of liver cancer and actively treat it; fourth: Pay attention to prevention Stop the recurrence of liver cancer.
In the above conversation, we learned that as long as we do a good job in fighting liver cancer, liver cancer is not an incurable disease. To understand what the specific anti-liver cancer link is, we must first understand what is liver cancer ?
1. What is liver cancer and what are the dangers of liver cancer?
liver cancer is a type of cancer, which includes metastatic liver cancer and primary liver cancer . We know that cancer will spread, and cancer cells will Metastasis occurs. A cancer cell appears in a certain part, and its source can be divided into the tissue itself, or other tissues, metastasis . Clinically, primary liver cancer generally refers to cancers in which the liver produces cancer cells themselves, including intrahepatic cholangiocarcinoma and hepatocellular liver cancer, and mixed liver cancer .
In addition, the opposite is metastatic liver cancer, that is, cancer cells come from other tissues. Through the lymph system or blood and other channels, cancer cells are metastasized on the liver, and then destroys the division of normal liver cells , thereby causing normal cells to develop into cancer cells . In clinical practice, patients with gastrointestinal tumors and breast malignant tumors and patients with cancer may have liver metastasis .
In the human body, cells divide in a limited number of . Cell apoptosis is the outcome of normal cells, but cancer cells break this rule. It is like wildfire in a wild forest. Once it occurs and is not controlled, it will be out of control. With the support of sufficient nutrients, cancer cells will reproduce infinitely to the body's tissues and organs brings a heavy burden, affecting the normal operation of the body .
When affecting the normal operation of the body, the immunity of of liver cancer patients will be affected to varying degrees, which will lead to a decrease in 's resistance ability. Compared with normal people, the probability of infection in patients with liver cancer will increase significantly. For example, in autumn and winter, the probability of cold is several times that of ordinary people , and the difficulty of getting cold improves is also several times that of normal people.
In addition to being prone to other diseases, the disease they suffer from will also affect in turn on the patient itself. Take a cold as an example. In addition to causing fever, runny nose, etc., it will also reduce the body's immunity. This will form a vicious cycle of , which will cause the liver cancer to gradually progress, causing patients to easily suffer from other diseases .
Among the dangers of liver cancer, the decrease in immunity is just a trivial one. The common dangers of liver cancer are ht. ml1 abdominal pain, easy bleeding , etc., these harms have far greater impact on patients than reducing immunity. Due to the impact of cancer, the liver of liver has long been riddled with .
patients will experience varying degrees of abdominal pain, and sometimes obvious peritoneal irritation, which can easily lead to a decrease in the patient's blood pressure, and then shock or even death . In addition, bleeding in patients with liver cancer, especially gastrointestinal bleeding , is also an important factor in the death of patients with liver cancer.
Gaptic tract bleeding in patients with liver cancer is generally caused by factors such as cirrhosis, reduction of coagulation factors, metastasis of liver cancer cells to the gastrointestinal mucosa, and other factors. Liver cancer is harmful to patients and has a great impact on life. If that is the case, how should we treat liver cancer? can control liver cancer or even cure it?
2. What are the treatments for liver cancer?
There are many treatments for liver cancer. It can be treated according to the primary liver cancer or metastatic liver cancer , or it can be treated according to the period of liver cancer. Liver cancer can be divided into early liver cancer, intermediate liver cancer, and advanced liver cancer according to the onset time and the patient's condition. In the above categories, early liver cancer is easier to treat and there is a possibility of radical cure.
In addition, depending on the treatment method, the treatment of liver cancer can also be divided into immunotherapy , surgical treatment , etc. In the early and middle stages of liver cancer, cancer treatment is generally the main focus. When liver cancer unfortunately develops to the late stage, it is mainly to improve the patient's quality of life and survival time . In short, in clinical practice, doctors need to choose the treatment method that is suitable for patients with according to the actual situation of patients with liver cancer.
Looking at liver cancer in a timeline, the most important treatment for liver cancer is mainly focused on early , because the effects and treatment expectations achieved in early liver cancer treatment are the greatest. If timely discover and correct treatment is correct, the possibility of cure is not lacking. In this case, what are the treatments for early liver cancer in and how should patients cooperate with doctors?
The treatment of early liver cancer includes surgical resection and radiofrequency ablation treatment of . The purpose is to eliminate cancer cells, prevent the regeneration and metastasis of cancer cells, and eliminate the possibility of liver cancer progress from the source. In the case of good physical condition of liver cancer patients, surgery can be performed to remove . Generally, it is necessary to remove in the concentrated area of liver cancer cells in the patient, which will destroy the possibility of transferring on a large area. After
, it is also necessary to ablate scattered liver cancer cell clustering area through radiofrequency ablation treatment under the location of CT or B-ultrasound , thereby causing cancer cells to lose the possibility of regeneration and further consolidate the effect of liver cancer treatment. This operation is generally suitable for patients with poor cardiopulmonary function and older age.
If we miss the treatment for early liver cancer, we cannot give up the treatment for middle and late liver cancer. Although the treatment effect at this time is not as good as early treatment, they can reduce the pain in patients with liver cancer , improve the patient's quality of life and survival time . Treatment of middle and advanced liver cancer includes immunotherapy, surgical treatment, radiation therapy, and traditional Chinese medicine treatment .
The first choice for the treatment of middle and advanced liver cancer is surgical treatment and radiation treatment , while immunotherapy and traditional Chinese medicine treatment are the supplementation for the above two treatments. In surgical treatment, partial hepatic resection and liver transplantation are generally preferred. The treatment principle of partial hepatic resection is also to remove the concentrated area of liver cancer cells. In addition, the surrounding areas of the concentrated area of cancer cells also require to remove .
Although the treatment effect of partial hepatic resection is quite satisfactory, the operation itself has great limitations. Generally, this surgery is suitable for people with cancer cell areas less than half of the liver. In addition, the operation also requires the patient not to have severe cirrhosis of , no obvious ascites, and distant metastasis of cancer cells. If the patient has the above situation, liver transplantation can be performed at this time.
liver transplantation treatment is not only suitable for the above situations, but also for early stage patients with liver cancer who have severe cirrhosis and are not suitable for surgical treatment or local ablation. After the treatment of liver transplantation and partial liver resection, although the condition of some liver cancer patients is controlled, liver cancer is still at risk of intrahepatic metastasis and distant metastasis .
In addition to the above risks, some patients will also be intolerant of liver transplantation and partial liver resection, which will easily affect the treatment effect and adverse reactions.Therefore, patients also need to consolidate the therapeutic effects of liver transplantation and partial liver resection through through immunotherapy and traditional Chinese medicine treatment.
liver cancer patients need to use Chinese medicines that analgesic and swelling, disperse and protect the liver, clear heat and detoxify for auxiliary treatment. In addition, liver cancer patients also need to undergo appropriate immunotherapy. Commonly used immunotherapy drugs include interferon , thymic peptide , and tumor necrosis factor , etc. If the above treatment is not effective and the cancer cells have local spread, the patient can undergo radiation therapy .
In the entire treatment process of liver cancer, whether it is early treatment or middle- and late treatment, it will more or less affect or harm the patient. Therefore, the prevention of liver cancer is particularly important. So what are the prevention measures for liver cancer ?
3. How to prevent liver cancer and how to prevent recurrence after suffering from liver cancer?
In terms of prevention, liver cancer can be divided into prevention of liver cancer and how to prevent recurrence after suffering from liver cancer. The former is to solve liver cancer from the source of , and the latter is to consolidate the therapeutic effect of to prevent liver cancer from relapse. Worldwide, the trend of liver cancer is generally on the rise. There are many factors that cause liver cancer, such as environmental factors, diet , etc., so preventing the occurrence of liver cancer is closely related to everyone.
Prevention of liver cancer requires starting from the cause of liver cancer. In daily life, you should eat less foods containing preservatives and additives, because most food additives and preservatives contain nitrate or nitrite . Nitrite is a recognized carcinogen , and nitrate is easily converted into nitrite under specific conditions. In addition, patients with liver disease can eat more foods that protect .
In addition to preventing the occurrence of liver cancer in life, we also need to actively treat diseases that occur in the liver and reduce the use of drugs that are harmful to the liver. For example, we need to actively treat diseases such as hepatitis B, hepatitis C , because if hepatitis B and hepatitis C are not actively treated, they will gradually develop into cirrhosis , which greatly increases the chance of liver cancer.
In addition to preventing the occurrence of liver cancer, it is also crucial to prevent the recurrence of liver cancer. In addition to life conditioning and active treatment of liver diseases, measures to prevent liver cancer recurrence include mentality conditioning and corresponding auxiliary treatment of . Patients with liver cancer need to pay attention to adjusting the psychological state of , face liver cancer with a positive and optimistic attitude, actively cooperate with doctors for treatment, and do not evade or dare not face it.
In addition to adjusting mentality, patients can also prevent the recurrence of liver cancer through hepatic artery perfusion chemotherapy, immunotherapy, and targeted treatment of . In addition to the above preventive measures, the most important thing is to conduct screening for preventing liver cancer, or monitoring of liver cancer condition .
Through liver cancer screening and monitoring of liver cancer condition , we can promptly discover whether liver cancer and the progress of liver cancer occur, and then make a quick and accurate judgment of as soon as possible so as not to miss early treatment of liver cancer. Because some patients with early stages of liver cancer have no symptoms and can only be found through examinations, it is recommended that normal people undergo liver cancer screening once every to per year.
Small summary
We must correctly understand liver cancer, face liver cancer correctly, and realize that liver cancer is not an incurable disease. In life, we must do a good job in life conditioning and disease care, so as not to give liver cancer an opportunity to take advantage of.
In addition, regular checks on and timely detection of liver cancer is also the top priority. If liver cancer unfortunately occurs, we must face it with the right attitude, cooperate with the doctor to actively treat it, and take protective measures for liver cancer to recur again.
References
【1】Du Yawei, Zhang Ningning, Lu Wei. Research status and prospects for liver cancer immunotherapy [J]. Journal of Practical Tumors , 2021, 36(05):393-398.
【2】Zong Jingjing, Qing Xin, Fan Zhe, Xu Wenjing, Zhang Yewei. Progress in the treatment of primary liver cancer [J]. Journal of Southeast University (Medical Edition), 2021, 40( 04):542-547.
【3】Zheng Jianhao, Dai Chaoliu. Diagnosis and treatment strategies for recurrent liver cancer [J]. Modern Oncology Medicine , 2021, 29(13):2381-2386.
【4】Yang Binghui, Zhang Boheng . Pay attention to the causes and prevention of liver cancer [J]. Journal of Clinical Hepatobiliary Diseases, 2012, 28(04):253-255.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-